Credit Suisse’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q2
Sell
-78,175
Closed -$297K 3553
2020
Q1
$297K Sell
78,175
-88,584
-53% -$337K ﹤0.01% 2836
2019
Q4
$848K Buy
166,759
+111,557
+202% +$567K ﹤0.01% 2623
2019
Q3
$279K Buy
55,202
+1,282
+2% +$6.48K ﹤0.01% 3069
2019
Q2
$333K Sell
53,920
-34,600
-39% -$214K ﹤0.01% 3000
2019
Q1
$410K Buy
88,520
+36,158
+69% +$167K ﹤0.01% 2878
2018
Q4
$221K Sell
52,362
-26,158
-33% -$110K ﹤0.01% 3110
2018
Q3
$492K Buy
78,520
+14,253
+22% +$89.3K ﹤0.01% 2842
2018
Q2
$517K Sell
64,267
-5,866
-8% -$47.2K ﹤0.01% 2950
2018
Q1
$523K Buy
70,133
+2,953
+4% +$22K ﹤0.01% 2924
2017
Q4
$401K Sell
67,180
-27,908
-29% -$167K ﹤0.01% 3036
2017
Q3
$699K Sell
95,088
-21,771
-19% -$160K ﹤0.01% 2878
2017
Q2
$793K Sell
116,859
-36,460
-24% -$247K ﹤0.01% 2487
2017
Q1
$1.45M Buy
153,319
+72,706
+90% +$687K ﹤0.01% 2264
2016
Q4
$697K Sell
80,613
-15,864
-16% -$137K ﹤0.01% 2927
2016
Q3
$612K Buy
96,477
+13,403
+16% +$85K ﹤0.01% 2985
2016
Q2
$351K Sell
83,074
-9,397
-10% -$39.7K ﹤0.01% 3322
2016
Q1
$404K Buy
92,471
+33,333
+56% +$146K ﹤0.01% 3071
2015
Q4
$362K Buy
59,138
+5,652
+11% +$34.6K ﹤0.01% 3360
2015
Q3
$306K Sell
53,486
-239,308
-82% -$1.37M ﹤0.01% 3490
2015
Q2
$2.19M Buy
292,794
+169,980
+138% +$1.27M ﹤0.01% 2267
2015
Q1
$734K Buy
122,814
+12,629
+11% +$75.5K ﹤0.01% 2989
2014
Q4
$833K Buy
110,185
+74,411
+208% +$563K ﹤0.01% 2962
2014
Q3
$186K Sell
35,774
-10,367
-22% -$53.9K ﹤0.01% 3766
2014
Q2
$199K Sell
46,141
-102,282
-69% -$441K ﹤0.01% 3944
2014
Q1
$607K Sell
148,423
-111,474
-43% -$456K ﹤0.01% 3198
2013
Q4
$1.39M Buy
259,897
+31,665
+14% +$169K ﹤0.01% 2620
2013
Q3
$1.15M Sell
228,232
-24,601
-10% -$123K ﹤0.01% 2459
2013
Q2
$1.13M Buy
+252,833
New +$1.13M ﹤0.01% 2350